Articles tagged with Weight Loss
A new study from the University of Surrey found that healthcare professionals face difficulties in recognizing and addressing disordered eating in people with type 1 Diabetes due to lack of support and limited confidence. This can lead to delays in diagnosis and potentially life-threatening complications for patients.
A recent study published in Heart journal found that extreme weight fluctuations significantly increase the risk of death among obese individuals with cardiovascular disease. Both weight loss and gain above 10kg raise mortality risk, highlighting the importance of maintaining a stable weight even within the obese range.
Replacing animal products with plant-based foods, even highly processed ones, can lead to substantial weight loss due to reduced calorie and fat intake and increased fiber consumption. This is according to a new analysis of a randomized clinical trial published in Nutrition & Metabolism.
A pooled data analysis found that water aerobics can effectively reduce overall weight and trim waist circumference by 3 cm in obese or overweight participants. Exercise periods lasting more than 10 weeks significantly reduced body weight and waist circumference in women and those aged 45 and older.
A study of 350 patients found that taking semaglutide before bariatric surgery did not increase total weight loss and had similar health outcomes to surgery alone. Researchers suggest a surgery-first strategy may lead to better obesity treatment outcomes.
A new study found that the proportion of visceral fat, rather than the absolute amount, is a stronger predictor of high triglyceride levels and inflammation. Lowering visceral fat proportion during weight loss can lead to better metabolic health outcomes.
Researchers developed a novel approach using electrospun poly(Lactic-co-Glycolic Acid) membrane with autologous cells to treat oral mucositis, a painful side effect of chemotherapy. The study showed significant results, with ulcers healed completely within six days and reduced inflammation.
Complimentary press passes are available for NUTRITION 2025, exploring cutting-edge research on nutrition and public health. Media professionals can attend in person or access virtual newsroom materials before the meeting.
A two-month intervention targeting ultra-processed foods resulted in a significant reduction of UPF intake, with participants consuming almost half the amount initially. Participants also experienced weight loss, improved mood, and reduced sugar, saturated fat, and sodium consumption.
A cohort study found that patients with obesity undergoing joint replacement who experienced significant weight loss after initiating anti-obesity medications had a lower risk of 5-year and 10-year revision. This suggests that safe and sustainable weight loss may improve implant survivorship in obese patients.
A systematic review of 38 studies found that frequent use of health and fitness apps is associated with problematic habits related to food and exercise. The research highlights the need for app developers to consider the psychological impacts of these tools on users' mental health.
Researchers found that teens with obesity consumed more calories in the late afternoon and early evening compared to their peers of healthy weight. The study, published in PNAS, demonstrates that the body's biological clock directly impacts food intake throughout the day.
Researchers found that bimagrumab increases bone tissue while building muscle mass, reducing the risk of osteoporosis. The study suggests bimagrumab could be part of a second-generation weight loss drug on the market.
A new study found that yo-yo dieting significantly increases the risk of kidney disease in people with type 1 diabetes. Participants who experienced greater weight fluctuations had a 40% decline in estimated glomerular filtration rate and were more likely to exhibit increased albuminuria.
A recent study published in Plastic and Reconstructive Surgery found that breast reduction surgery can lead to weight gain in adolescents and young women, particularly those who were at a healthy body mass index (BMI) before surgery. The study suggests that these patients should be targeted for healthy lifestyle changes to prevent weig...
A recent study by Murdoch University reveals that moderate-intensity exercise significantly influences appetite-related hormones and perceptions in males with obesity. The study confirms the benefits of incorporating regular exercise into daily routines for weight management and overall health improvement.
The University of Illinois team developed MealPlot, an interactive feature that charts protein and fiber content in food. The app helps individuals plan meals with a focus on high protein and fiber density to achieve a calorie deficit while maintaining muscle mass.
A new study from the Salk Institute has discovered that a protein called BCL6 plays a crucial role in maintaining healthy muscle mass. Increasing BCL6 levels successfully reversed muscle losses in mice, suggesting that pairing GLP-1 medications with a BCL6-boosting drug could help counteract unwanted muscle loss.
A new study found disparities in access to semaglutide based on insurance plan, job industry, sex, and other factors. Individuals with female identities, preferred provider organization coverage, and antidepressant use were more likely to start taking semaglutide compared to males or those with certain employment industries.
A large population-based analysis found that genetic variants in the GLP1R gene are associated with cardiometabolic traits and behavioral changes, such as risk-taking behavior and anxiety. These findings suggest that any observed behavioral changes with GLP1RA medications are unlikely to be a direct result of the medication.
A recent study published in Nature Medicine analyzed over 2 million veterans taking GLP-1RA medications, finding benefits to cognitive and behavioral health while revealing increased risks for pancreatitis and kidney conditions. The study also showed decreased risks of seizures, addiction, suicidal ideation, and neurocognitive disorders.
A new Cochrane review found that calorie labelling in supermarkets, restaurants, and other food outlets leads to a small reduction in the calories people select and purchase. The average reduction was 1.8%, equating to around two almonds per 600-calorie meal.
A new study by Mass General Brigham investigators found that Black people were less likely than non-Black people to undergo metabolic and bariatric surgery, even though both groups were equally likely to discuss it with health care providers. Men were also less likely to discuss and receive MBS than women.
A new national survey by Orlando Health finds that 56% of Americans are unaware that bariatric surgery is an effective way to improve fertility. Bariatric surgery has been shown to regulate hormones and normalize menstrual cycles, increasing a woman's chances of conception. The study highlights the connection between obesity and infert...
Researchers analyzed cost-effectiveness of semaglutide for non-diabetic overweight/obese individuals with heart disease. With price reductions, semaglutide shows promise in reducing lifetime costs and improving health outcomes.
A 12-week study found that intermittent fasting, especially time-restricted eating, leads to greater weight loss and reduced abdominal subcutaneous fat compared to a nutrition education programme. This study suggests that this strategy can be an effective method for improving cardiovascular health in people with obesity problems.
A systematic review of randomized controlled trials found GLP-1 RAs and co-agonists to be effective for weight loss in adults with obesity, including promising options not yet FDA-approved. The study also showed similar safety profiles across agents, with mild gastrointestinal side effects being the most common.
A recent survey found that nearly half of U.S. adults plan to start a new diet in 2025, with the most common diets being low-calorie and low-carbohydrate options. However, plant-based diets have been shown to be effective for weight loss without restricting or counting calories, and also reduce the risk of obesity-related diseases.
Engaging in 30 minutes of aerobic exercise per week modestly reduces body weight, waist circumference, and body fat measures. Aerobic training exceeding 150 minutes per week may be needed for clinically important reductions.
A study published in PLOS Biology found that individuals with and without obesity prefer high-calorie foods, regardless of their taste or texture. The researchers used a large group of healthy volunteers to compare food preferences among three groups: individuals with obesity, post-bariatric surgery patients, and non-obese controls.
A cross-sectional study found substantial projected annual savings from weight loss among U.S. adults with obesity, particularly for Medicare and employer-based insurance. The estimated reduction in healthcare spending is substantial, offering a potential benefit for individuals with obesity.
A new type of gastric balloon has been designed to help people lose weight by making them feel too full to overeat. The balloon can be inflated and deflated as needed, and animal studies have shown that it can reduce food intake by 60 percent before meals.
A systematic review of 18 randomized controlled trials found that drinking enough water can help with weight loss and prevent kidney stones. Drinking eight cups a day significantly decreased the likelihood of getting another kidney stone, while six cups a day helped adults lose weight.
A new study led by Weill Cornell Medicine found that tirzepatide reduced the risk of diabetes in obese and prediabetic patients by more than 90% after 176 weeks. The treatment also showed significant weight loss and improved blood sugar control.
A cohort study found that nearly half of participants who consumed alcohol at baseline decreased their alcohol use after initiating anti-obesity medication treatment. The medications, such as naltrexone and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), may have properties that lead to reduced cravings for alcohol.
A study estimates that approximately one-third of eligible US adults without diabetes were excluded from clinical trials supporting GLP-1 and GLP-1/GIP medications. The FDA should consider updating labeling to advise caution on generalizing these medications' safety and effectiveness to excluded populations.
A new study finds that replacing meat and dairy products with plant-based foods leads to a 92% reduction in hot flashes in postmenopausal women. The study also shows weight loss in both healthy and unhealthy plant-based diets, suggesting even 'unhealthy' plant-based foods can be beneficial.
A study of U.S. adults on anti-obesity medications found that 25% reported wasting more food since taking the drugs, while changes in diet and eating habits appeared to offset some of this waste, particularly among those who consumed more vegetables.
Research suggests that lifestyle modifications and metformin do not improve atrial fibrillation (AFib) burden or progression when compared to standard care. In contrast, weight loss and exercise resulted in decreased AFib symptoms in patients with the condition.
The study aims to confirm initial findings suggesting that increased step counts correlate with improved health indicators, such as reduced body fat and lower insulin levels. By establishing a model, the team hopes to provide healthcare professionals with a tool to recommend tailored walking goals for their patients.
Studies published in JACC found that anti-obesity drugs such as tirzepatide and semaglutide improved cardiac structure and function, as well as reduced cardiac risk biomarkers with lifestyle interventions. These findings suggest that these treatments may have a transformative impact on cardiovascular health beyond weight loss.
The international SUMMIT trial found tirzepatide lowered the risk of worsening heart failure events and cardiovascular death in obese adults with preserved ejection fraction. Participants experienced improved health status, physical function, and exercise tolerance compared to placebo.
Scientists have discovered a new weight loss drug target that increases calorie-burning and lowers appetite without causing nausea. The discovery could lead to a new therapy for millions of people with obesity and type 2 diabetes.
A study by the University of Gothenburg found that unclear procedures and distribution of responsibilities among healthcare workers can lead to poor oral health in older adults in nursing homes. The researchers suggest that a more structured process can promote communication and awareness of good oral health practices.
A team of researchers has discovered a previously unknown metabolic pathway involving beta-hydroxybutyrate (BHB), a key ketone body. This finding suggests that ketones have additional roles in the body's metabolic landscape, potentially influencing appetite suppression and weight regulation under ketosis conditions.
A systematic review found that weight-loss interventions were associated with improvements in some polycystic ovary syndrome (PCOS) symptoms, including improved menstrual frequency. The interventions also showed a clinically significant improvement in metabolic markers and hormonal balance.
A study of 260 teens who underwent bariatric surgery at age 13-19 found that over half demonstrated sustained weight loss and resolution of conditions like type 2 diabetes. After 10 years, 55% of participants with type 2 diabetes remained in remission.
A study found that increasing ketones through a keto diet or supplements can change menstrual frequency and intensity in pre-menopausal women. The research suggests that the presence of ketones, rather than weight loss, may regulate women's health.
Medically induced weight loss with GLP-1 receptor agonists can lead to substantial muscle loss, compromising physical strength and immune function. The authors emphasize the need for a multimodal approach combining medication with exercise and nutritional interventions to preserve muscle mass.
A recent study found that the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023, while rates of metabolic bariatric surgery dropped by one quarter. This shift in treatment options has implications for access to comprehensive multidisciplinary care for obesity.
A study conducted by Hiddo L. Heerspink at the University Medical Center Groningen found that Ozempic reduced protein in urine by 52% and decreased kidney inflammation by 30%, as well as lowering blood pressure and reducing a key measure of heart failure
Two studies found that bariatric surgery is more cost-effective in the long term compared to GLP-1 RA weight loss drugs alone. Combining both treatments is even more cost-effective. The use of GLP-1 RA before surgery appears safe and may be a novel approach to treating obesity.
The EAT2 study, led by Dr. Ursula White, investigates the lasting health effects of short-term weight gain and loss on fat tissue and overall health. Participants will undergo a dietary intervention program followed by an eight-week weight loss treatment.
A systematic review and meta-analysis found that weight-loss surgery reduces pancreatic cancer risk among individuals with obesity by 44%, and among those with both obesity and type 2 diabetes by 79%. The study suggests that metabolic-bariatric surgery may play a crucial role in reducing the risk of pancreatic cancer.
A recent study by The Jackson Laboratory reveals that reducing calorie intake can significantly extend the lifespan of mice, with the most robust animals living the longest. However, the researchers found that losing weight on these diets had a negative impact on lifespan in humans.
A recent study discovered 14 'skinny genes' associated with significant weight loss in response to regular exercise. Participants who carried more of these genes lost up to 5kg during an eight-week period. Exercise was found to be crucial for unlocking the full potential of these genes, emphasizing the importance of lifestyle changes.
A new study from the University of Waterloo suggests that men and women should eat different breakfasts to lose weight. The research found that men's metabolisms respond better to high-carbohydrate meals after fasting, while women are better served by higher-fat meals.
A randomized controlled trial found that time-restricted eating (TRE) led to greater improvements in glucose control, weight loss, and fat reduction compared to standard nutrition counseling in adults with metabolic syndrome. TRE resulted in a lower risk of muscle mass loss during weight loss.
A new study finds that preventive health technologies can support healthy routines but also lead to compulsive usage, ultimately harming users. Consumers' experiences with these technologies vary, from increased engagement to reduced interest and obsessive behavior.
A new study demonstrates the potential of semaglutide in treating hidradenitis suppurative (HS) in people with obesity. The results show marked improvements in patient outcomes across several key measures, including reduced flare frequency, improved quality of life, and better glycaemic control.